BREAKTHROUGH CAR T-CELL THERAPY SHOWS PROMISE IN GLIOBLASTOMA TREATMENT
• arcleinThe first patient, a 74-year-old man, witnessed significant tumor reduction within a day of CARv3-TEAM-E T-Cell infusion. However, subsequent scans revealed cancer progression months later despite initial improvement. Similarly, a 57-year-old woma